汉森制药(002412.SZ)：中药新药苁蓉颗粒正处于工艺中试放大研究阶段

Core Viewpoint - Hansen Pharmaceutical (002412.SZ) is currently in the process of scaling up the research for its new traditional Chinese medicine product, Cangrong Granules, which is in the stage of pilot testing [1] Group 1 - The company is focusing on research and development in the field of traditional Chinese medicine [1] - Cangrong Granules is a new drug under development by the company [1] - The current phase of research involves pilot testing for process scaling [1]